Titles
- The "deemed to be a license" provision of the BPCI Act: questions and answers1
- The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff1
- The Elijah E. Cummings Lower Drug Costs Now Act: how it would work, how it would affect prices, and what the challenges are1
- The Families First Coronavirus Response Act: Medicaid and CHIP provisions explained1
- The Impact of federal value-based primary care programs on participating Oregon Practices: a snapshot1
- The Office of Refugee Resettlement’s incident reporting system is not effectively capturing data to assist its efforts to ensure the safety of minors in HHS custody1
- The behavioral health crisis: a road map for academic health center leadership in healing our nation1
- The benefits and limitations of state-run individual market reinsurance1
- The budget and economic outlook: 2020 to 20301
- The changing landscape: tobacco and marijuana use among young adults in California1
- The economics of vaccine development and supply: responding to COVID-19 and preparing for the next threat1
- The effects of Medicaid expansion under the ACA: updated findings from a literature review1
- The effects of large group meetings on the spread of COVID-19: the case of Trump rallies1
- The effects of pandemic-related legislation on output1
- The evolving landscape of national telehealth policies during a public health emergency: responsiveness to rural needs1
- The fiscal impact of the Trump Administration’s Medicaid block grant initiative1
- The health insurance policy simulation model for 2020: current-law baseline and methodology1
- The impact of the minimum wage on DI participation1
- The impacts of COVID-19 on minority unemployment: first evidence from April 2020 CPS microdata1
- The implications of Medicaid expansion in the remaining states: 2020 update1